Flexible Work
AARP Skills Builder
Flexible Work
ON-DEMAND WEBINARS
Drug Prices
Social Security
Medicare & Medicaid
Caregiving
LONG-TERM CARE
State Guides
Prepare to Care Guides
End of Life
Home Technology
Get Happier
POSSIBILITIES OF AI
Relationships
Home Health
Leaving AARP.org Website
You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
BrandAmp by AARP provides the opportunity for our highly vetted marketing partners to share their expert knowledge, insights and storytelling with loyal and engaged readers like you. Each piece of paid content is created in collaboration with the disclosed advertiser and AARP Media Sales’ content development team.
BrandAmp by AARP content is designed to uphold AARP standards of excellence and inspire conversation. Only advertisers who have gone through the strictest reviews are cleared to bring their message directly to members using all of AARP media properties (AARP.org, social media, email newsletters and our print publications). Our pledge to members is work with brands whose products and services are of value to the 50+ audience; and are committed to the type of compelling, informative, entertaining and useful content members are accustomed to seeing within AARP media properties.
You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
Two more brands of eye drops have been recalled due to contamination risks that could cause adverse reactions, including eye infections that could lead to blindness.
The Food and Drug Administration (FDA) issued recall notices for eye drop manufacturers Pharmedica and Apotex, citing contamination concerns. In February, EzriCare Artificial Tears were recalled after being linked to antibiotic-resistant infections. At least 55 cases were reported, which resulted in vision loss, hospitalization and one death.
Two lots of Pharmedica’s Purely Soothing 15% MSM Drops, used to treat eye inflammation and irritation, were recalled due to non-sterility. The products were sold worldwide at trade shows and at online retailers, including Amazon.com. Pharmedica advises consumers to immediately stop using the recalled products and return them to the place of purchase. Questions can be directed to the company by phoning 623-698-1752 from 8 a.m. to 5 p.m. MT or by email to osm@pharmedicausa.com.
The recalled batches include lot #2203PS01, sold in a 1-ounce bottle, and lot #1808051, sold in half-ounce bottles.
Apotex pulled six lots of its Brimonidine Tartrate Ophthalmic Solution, 0.15% because the bottle caps may be cracked, causing the solution to become unsterile. The product is used by patients with open-angle glaucoma or ocular hypertension. Patients who purchased the recalled lots should contact their pharmacy and their health care provider for medical advice. The drops may be returned to Inmar Rx Solutions by calling 855-275-1273 from 9 a.m. to 5 p.m. ET.
The affected lot numbers are TJ9848 and TJ9849 with an expiration date of February 2024, and TK0258, TK5341, TK0261 and TK0262 with an April 2024 expiration date.
There have been no reports of injury or adverse events related to either of the newly recalled eye drops. There are no known connections to the February recall of Ezricare Artificial Tears.
Adverse reactions or quality problems from the use of these products may be reported to the FDA’s MedWatch adverse event reporting program, online, by regular mail or by calling 800-332-1088.
More From AARP
Eye Drop Recall: Infections and Deaths Rise
Some cases resulted in permanent blindness
What Your Eye Color Can Say About Your Health
Plus, 8 types of changes in eye color that indicate problems